All stock lists
Sana Biotechnology, Inc. (NASDAQ:SANA)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
2.38+0.04 (+1.93%)
Insider Score
––Not scored
SANA Insider Score
Insiders here have filed 3 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
SANA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 2.39 M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | -2.39 M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 10.78 M | 11.46 M | 12.19 M | 10.29 M | 10.34 M | 11.48 M |
| R&D Expense | 54.64 M | 24.02 M | 49.01 M | 33.23 M | 40.02 M | 39.15 M |
| Operating Expenses | 65.42 M | 35.48 M | 61.20 M | 43.52 M | 94.97 M | 50.63 M |
| Operating Income | -65.42 M | -37.87 M | -61.20 M | -43.52 M | -94.97 M | -50.63 M |
| Pretax Income | -63.63 M | -47.21 M | -58.83 M | -42.15 M | -93.80 M | -49.39 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -63.63 M | -47.21 M | -58.83 M | -42.15 M | -93.80 M | -49.39 M |
| EPS (Basic) | -0.22 | -0.17 | -0.21 | -0.16 | -0.39 | -0.21 |
| EPS (Diluted) | -0.22 | -0.17 | -0.20 | -0.16 | -0.39 | -0.21 |
| Shares Outstanding | 295.67 M | 276.86 M | 253.23 M | 260.49 M | 238.41 M | 237.58 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.